RIT Biotech Company Limited

RIT Biotech Company Limited is dedicated to providing top-quality biotechnology research and services. Located in Hong Kong at 9 Lok Yip Road, Fanling, New Territories, RIT Biotech is committed to serving the radiopharmaceutical industry by delivering innovative radiopharmaceuticals and continuously improving service quality for nuclear medicine and clinical oncology specialties.

RIT Biotech Company Limited holds an Authorized Seller of Poison (ASP) license, granted by the Department of Health, HKSAR. This distinction underscores RIT Biotech's commitment to complying with the stringent requirements of current Good Radiopharmacy Practices (Part A) in the preparation of radiopharmaceuticals (cGRPP), as set out by the European Association of Nuclear Medicine (EANM). Through rigorous cGRPP production and operational practices, RIT Biotech ensures the highest standards of quality assurance and compliance with Cap 138 Pharmacy & Poison Ordinance in Hong Kong.

As a leader in the field, RIT Biotech’s cGRPP Part A license is the first and only license granted in Hong Kong for SPECT/conventional radiopharmacy for nuclear medicine and clinical oncology. RIT Biotech Company Limited continues to strive for excellence in biotechnology research and development. We invite the management of RIT Biotech to create a customized and exclusive company showcase and product listing on our platform.